Following the identification of these key genetic aberrations in GBM, Eckel-Passow et al. investigated the significance and association to survival of three markers for defining molecular groups in gliomas, namely chromosome arms 1p and 19q, IDH mutations, and TERT promoter mutations. The gene discussed is IDH1; the disease is central nervous system cancer.